166 related articles for article (PubMed ID: 24986024)
1. ROS and p53 in regulation of UVB-induced HDM2 alternative splicing.
Tong L; Wu S
Photochem Photobiol; 2015; 91(1):221-4. PubMed ID: 24986024
[TBL] [Abstract][Full Text] [Related]
2. The Involvement of Splicing Factor hnRNP A1 in UVB-induced Alternative Splicing of hdm2.
Feng J; Li L; Tong L; Tang L; Wu S
Photochem Photobiol; 2016 Mar; 92(2):318-324. PubMed ID: 26757361
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability.
Dias CS; Liu Y; Yau A; Westrick L; Evans SC
Cancer Res; 2006 Oct; 66(19):9467-73. PubMed ID: 17018602
[TBL] [Abstract][Full Text] [Related]
4. Identification of spliced variants of the proto-oncogene HDM2 in colorectal cancer.
Yu Z; Zhang B; Cui B; Wang Y; Han P; Wang X
Cancer; 2012 Feb; 118(4):1110-8. PubMed ID: 21761395
[TBL] [Abstract][Full Text] [Related]
5. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
Latonen L; Taya Y; Laiho M
Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
Sánchez-Aguilera A; García JF; Sánchez-Beato M; Piris MA
Oncogene; 2006 Apr; 25(18):2565-74. PubMed ID: 16331255
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
[TBL] [Abstract][Full Text] [Related]
8. ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation.
de Toledo SM; Azzam EI; Dahlberg WK; Gooding TB; Little JB
Oncogene; 2000 Dec; 19(54):6185-93. PubMed ID: 11175332
[TBL] [Abstract][Full Text] [Related]
9. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
10. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.
Heminger K; Markey M; Mpagi M; Berberich SJ
Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors suppress the protein expression of mutant p53.
Halasi M; Pandit B; Gartel AL
Cell Cycle; 2014; 13(20):3202-6. PubMed ID: 25485499
[TBL] [Abstract][Full Text] [Related]
12. Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells.
Sui X; Shin S; Zhang R; Firozi PF; Yang L; Abbruzzese JL; Reddy SA
Oncogene; 2009 Feb; 28(5):709-20. PubMed ID: 19029954
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
14. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.
Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F
Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988
[TBL] [Abstract][Full Text] [Related]
15. An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2.
Evans SC; Viswanathan M; Grier JD; Narayana M; El-Naggar AK; Lozano G
Oncogene; 2001 Jul; 20(30):4041-9. PubMed ID: 11494132
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.
Koblish HK; Zhao S; Franks CF; Donatelli RR; Tominovich RM; LaFrance LV; Leonard KA; Gushue JM; Parks DJ; Calvo RR; Milkiewicz KL; Marugán JJ; Raboisson P; Cummings MD; Grasberger BL; Johnson DL; Lu T; Molloy CJ; Maroney AC
Mol Cancer Ther; 2006 Jan; 5(1):160-9. PubMed ID: 16432175
[TBL] [Abstract][Full Text] [Related]
17. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression.
Bárdos JI; Chau NM; Ashcroft M
Mol Cell Biol; 2004 Apr; 24(7):2905-14. PubMed ID: 15024078
[TBL] [Abstract][Full Text] [Related]
18. Suppression of p53 activity by Siva1.
Du W; Jiang P; Li N; Mei Y; Wang X; Wen L; Yang X; Wu M
Cell Death Differ; 2009 Nov; 16(11):1493-504. PubMed ID: 19590512
[TBL] [Abstract][Full Text] [Related]
19. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
20. Hdm2 and nitric oxide radicals contribute to the p53-dependent radioadaptive response.
Takahashi A; Matsumoto H; Ohnishi T
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):550-8. PubMed ID: 18410999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
